HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report)’s stock price shot up 1.6% during trading on Thursday . The stock traded as high as $2.54 and last traded at $2.54. 1,700 shares were traded during trading, a decline of 62% from the average session volume of 4,473 shares. The stock had previously closed at $2.50.
HLS Therapeutics Stock Up 1.6 %
The business’s fifty day simple moving average is $2.53 and its two-hundred day simple moving average is $2.67.
About HLS Therapeutics
HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.
See Also
- Five stocks we like better than HLS Therapeutics
- Using the MarketBeat Stock Split Calculator
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Investing in Construction Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
